Medline Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	2,236	1,939	199	1,556
Cash & Short-Term Investments	2,236	1,939	199	1,556
Cash Growth	285.52%	874.37%	-87.21%	-
Accounts Receivable	3,674	3,533	3,219	2,960
Inventory	4,807	4,769	4,456	3,813
Other Current Assets	463	438	398	480
Total Current Assets	11,180	10,679	8,272	8,809
Net Property, Plant & Equipment	4,758	4,778	4,595	4,501
Other Intangible Assets	13,717	13,893	14,559	14,788
Goodwill	8,076	8,079	8,065	7,532
Other Long-Term Assets	1,283	1,055	487	492
Total Assets	39,014	38,484	35,978	36,122
Accounts Payable	932	961	869	696
Accrued Expenses	1,527	1,452	1,493	1,351
Current Portion of Long-Term Debt	77	77	78	75
Other Current Liabilities	-	-	-	9
Total Current Liabilities	2,536	2,490	2,440	2,131
Long-Term Debt	12,495	12,484	16,416	16,442
Other Long-Term Liabilities	4,634	4,224	598	572
Total Long-Term Liabilities	17,129	16,708	17,014	17,014
Total Liabilities	19,665	19,198	19,454	19,145
Common Stock	-	-	-	16,556
Additional Paid-in Capital	11,132	10,717	-	-
Accumulated Other Comprehensive Income	18	27	11	188
Retained Earnings	122	-7	16,147	-
Total Common Shareholders' Equity	11,272	10,737	16,158	16,744
Minority Interest	8,077	8,549	366	233
Shareholders' Equity	19,349	19,286	16,524	16,977
Total Liabilities & Equity	39,014	38,484	35,978	36,122
Total Debt	12,572	12,561	16,494	16,517
Net Cash (Debt)	-10,336	-10,622	-16,295	-14,961
Net Cash Per Share	-12.22	-13.11	-	-
Book Value	11,272	10,737	16,158	16,744
Book Value Per Share	13.32	13.26	-	-
Tangible Book Value	-10,521	-11,235	-6,466	-5,576
Tangible Book Value Per Share	-12.44	-13.87	-	-

SEC Filings: 10-K · 10-Q